In the US, Probenecid (probenecid systemic) is a member of the drug class antigout agents and is used to treat Adjunct to Antibiotic Therapy and Gout.
US matches:
- Probenecid
- Probenecid and colchicine
- Probenecid Colchicine
- Probenecid Tablets
- Probenecid/Colchicine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
M04AB01
CAS registry number (Chemical Abstracts Service)
0000057-66-9
Chemical Formula
C13-H19-N-O4-S
Molecular Weight
285
Therapeutic Category
Uricosuric agent
Chemical Name
Benzoic acid, 4-[(dipropylamino)sulfonyl]-
Foreign Names
- Probenecidum (Latin)
- Probenecid (German)
- Probénécide (French)
- Probenecida (Spanish)
Generic Names
- Probenecid (OS: DCIT, JAN, BAN)
- Probénécide (OS: DCF)
- Probenecid (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XIV)
- Probénécide (PH: Ph. Eur. 6)
- Probenecidum (PH: Ph. Int. 4, Ph. Eur. 6)
Brand Names
- Bencid
Geno, India
- Benecid
Kaken Seiyaku, Japan; Valdecasas, Mexico
- Benemid
Merck Sharp & Dohme, Ethiopia
- Benemide
Bouchara, France
- Benuryl
Teva, Israel; Valeant, Canada
- Mydrox (Probenecid and Cefadroxil)
Solitaire, India
- Probalan
Lannett, United States
- Probecid
BioPhausia, Norway; BioPhausia, Sweden
- Proben
Aspen Pharmacare, South Africa
- Probenecid Medic
Medic, Denmark
- Probenecid Synco
Synco, Hong Kong
- Probenecid Weimer
Biokanol, Germany
- Probenecid
AFT, New Zealand; Mylan, United States; Watson, United States; Watson, United States
- Procid
Johnson, Taiwan
- Pro-Cid
Phebra, Australia
- Santuril
Lipomed, Switzerland
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and
International Nonproprietary Names.